Tetraphase is fighting one of the most significant threats to humanity — antibiotic resistance — through the promise of our technology and the passion of our people. We are committed to making novel antibiotics accessible to all patients in need.
According to The Review on Antimicrobial Resistance (May 2016), by 2050, antimicrobial resistance is projected to kill more people than cancer and diabetes combined. At Tetraphase, the fight against antimicrobial resistance is at the core of who we are as a company. It unites us in a common goal and fuels our determination to develop new antibiotics that can overcome the challenges of drug-resistant bacteria and ensure the availability of effective treatments in the future.
By virtue of our size, novel technology, and well-defined mission targeting antibiotic resistance, Tetraphase has the focus and flexibility to explore a broad range of antibiotic solutions.
Our lead product, XERAVA, is approved for the treatment of complicated intra-abdominal infections (cIAI), find out more at XERAVA.com
Company Details
- Employees
- 14
- Founded
- -
- Address
- 480 Arsenal St, Watertown,massachusetts 02472,united States
- Phone
- 6179263557
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- tphase.com
- Keywords
- Antibiotics, Gram-negative antibiotics, multidrug-resistant infections, antibiotic resistance, biopharmaceutical, bacterial resistance.
- HQ
- Watertown, Massachusetts
Tetraphase Pharmaceuticals Questions
Tetraphase Pharmaceuticals's helpline number is 6179263557
Tetraphase Pharmaceuticals's website is tphase.com
Tetraphase Pharmaceuticals's LinkedIn profile is https://www.linkedin.com/company/tetraphase-pharmaceuticals
Tetraphase Pharmaceuticals has
14 employees.
View email and phone details for 14
employees at Tetraphase Pharmaceuticals.
Tetraphase Pharmaceuticals's industry is
Biotechnology Research
Tetraphase Pharmaceuticals's top competitors are
Aicuris Anti-Infective Cures Ag,
Ucb,
Vor Bio,
Karyopharm Therapeutics Inc.,
La Jolla Pharmaceutical Company,
Alnylam Pharmaceuticals,
Seres Therapeutics,
Alexion Pharmaceuticals, Inc.,
Akebia Therapeutics,
Spero Therapeutics.
Tetraphase Pharmaceuticals's categories are Biotechnology Research
Tetraphase Pharmaceuticals's founding year is 2006
